486 related articles for article (PubMed ID: 21532565)
1. Harnessing synthetic lethal interactions in anticancer drug discovery.
Chan DA; Giaccia AJ
Nat Rev Drug Discov; 2011 May; 10(5):351-64. PubMed ID: 21532565
[TBL] [Abstract][Full Text] [Related]
2. A lethal combination for cancer cells: synthetic lethality screenings for drug discovery.
Ferrari E; Lucca C; Foiani M
Eur J Cancer; 2010 Nov; 46(16):2889-95. PubMed ID: 20724143
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Lethal Interactions in Cancer Therapy.
Geng X; Wang X; Zhu D; Ying S
Curr Cancer Drug Targets; 2017; 17(4):304-310. PubMed ID: 27113746
[TBL] [Abstract][Full Text] [Related]
4. The concept of synthetic lethality in the context of anticancer therapy.
Kaelin WG
Nat Rev Cancer; 2005 Sep; 5(9):689-98. PubMed ID: 16110319
[TBL] [Abstract][Full Text] [Related]
5. The role of drug-metabolizing enzymes in synthetic lethality of cancer.
Zeng Z; Zheng W; Hou P
Pharmacol Ther; 2022 Dec; 240():108219. PubMed ID: 35636517
[TBL] [Abstract][Full Text] [Related]
6. [Synthetic lethality as a functional tool in basic research and in anticancer therapy].
Toma M; Skorski T; SliwiĆski T
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1091-103. PubMed ID: 25228518
[TBL] [Abstract][Full Text] [Related]
7. Syn-lethality: an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies.
Li XJ; Mishra SK; Wu M; Zhang F; Zheng J
Biomed Res Int; 2014; 2014():196034. PubMed ID: 24864230
[TBL] [Abstract][Full Text] [Related]
8. Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.
Topatana W; Juengpanich S; Li S; Cao J; Hu J; Lee J; Suliyanto K; Ma D; Zhang B; Chen M; Cai X
J Hematol Oncol; 2020 Sep; 13(1):118. PubMed ID: 32883316
[TBL] [Abstract][Full Text] [Related]
9. PARP inhibition as a prototype for synthetic lethal screens.
Liu X
Methods Mol Biol; 2013; 986():123-37. PubMed ID: 23436410
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lethal interactions for the development of cancer therapeutics: biological and methodological advancements.
Mizuarai S; Kotani H
Hum Genet; 2010 Dec; 128(6):567-75. PubMed ID: 20976469
[TBL] [Abstract][Full Text] [Related]
11. Embracing synthetic lethality of novel anticancer therapies.
Kamal A; Shaik TB; Malik MS
Expert Opin Drug Discov; 2015 Oct; 10(10):1119-32. PubMed ID: 26211783
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T
FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326
[TBL] [Abstract][Full Text] [Related]
13. Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.
Gautam P; Karhinen L; Szwajda A; Jha SK; Yadav B; Aittokallio T; Wennerberg K
Mol Cancer; 2016 May; 15(1):34. PubMed ID: 27165605
[TBL] [Abstract][Full Text] [Related]
14. Synthetic lethality on drug discovery: an update on cancer therapy.
Yar MS; Haider K; Gohel V; Siddiqui NA; Kamal A
Expert Opin Drug Discov; 2020 Jul; 15(7):823-832. PubMed ID: 32228106
[TBL] [Abstract][Full Text] [Related]
15. Complex synthetic lethality in cancer.
Ryan CJ; Devakumar LPS; Pettitt SJ; Lord CJ
Nat Genet; 2023 Dec; 55(12):2039-2048. PubMed ID: 38036785
[TBL] [Abstract][Full Text] [Related]
16. Integrating genetic approaches into the discovery of anticancer drugs.
Hartwell LH; Szankasi P; Roberts CJ; Murray AW; Friend SH
Science; 1997 Nov; 278(5340):1064-8. PubMed ID: 9353181
[TBL] [Abstract][Full Text] [Related]
17. Application of the concept synthetic lethality toward anticancer therapy: a promise fulfilled?
Canaani D
Cancer Lett; 2014 Sep; 352(1):59-65. PubMed ID: 23962561
[TBL] [Abstract][Full Text] [Related]
18. Synthetic lethality as an engine for cancer drug target discovery.
Huang A; Garraway LA; Ashworth A; Weber B
Nat Rev Drug Discov; 2020 Jan; 19(1):23-38. PubMed ID: 31712683
[TBL] [Abstract][Full Text] [Related]
19. Malignancy of Cancers and Synthetic Lethal Interactions Associated With Mutations of Cancer Driver Genes.
Wang X; Zhang Y; Han ZG; He KY
Medicine (Baltimore); 2016 Feb; 95(8):e2697. PubMed ID: 26937901
[TBL] [Abstract][Full Text] [Related]
20. Synthetic lethal vulnerabilities of cancer.
Fece de la Cruz F; Gapp BV; Nijman SM
Annu Rev Pharmacol Toxicol; 2015; 55():513-31. PubMed ID: 25340932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]